FDA Clears AdvanDx Fungal Test Speed-up | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagnostics test developer AdvanDx said today that it has received 510(k) clearance from the US Food and Drug Administration for a new protocol that speeds up results for two of its tests for fungal bloodstream infection.

The protocol cleared by FDA reduces the time for results for its PNA FISH tests for Candida albicans and for C. glabrata from two 2.5 hours to 90 minutes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.